Find more information about the following subjects:
- Vol. 30, No. 2 Low Endotoxin Recovery (LER): A Review
- Vol. 30, No. 1 Pyrosate® Improved and Now FDA Licensed
- Vol. 29, No. 1 Revision of the United States Pharmacopoeia Bacterial Endotoxin Test Chapter
- Vol. 28, No. 1 The New FDA Guidance for Industry “Pyrogen and Endotoxins Testing: Questions and Answers”
- Vol. 27, No. 1 Withdrawal of FDA Guideline
- Vol. 26, No. 1 Revisions to the Pharmacopeial Bacterial Endotoxins Test Chapters
- Vol. 25, No. 1 Controls for Photometric Tests: Implications for Low Capacity Test Systems
- Vol. 24, No. 2 New From Associates of Cape Cod: Pyros® EQS Software
- Vol. 24, No. 1 Endotoxin Testing of Cellular and Tissue Based Therapies
- Vol. 23, No. 2 Testing Blood Samples for Endotoxin
- Vol. 22, No. 3 Interference with the LAL Test and How to Address It
- Vol. 20, No. 3 (1,3)-b-D Glucan Contamination of Cotton-Containing Medical Devices: (Sources, Measurement, and Implications)
- Vol. 16, No. 1 Significance of Endotoxin to Cell Culture and Biotechnology
- Vol. 14, No. 2 LAL: Discovery and Commercial Development
- Vol. 14, No. 1 Preliminary Testing
- Vol. 13, No. 4 Maximum Valid Dilution and Minimum Valid Concentration
- Vol. 13, No. 3 A Wealth of Options: Choosing an LAL Test Method
- Vol. 13, No. 2 Endotoxin Limits
- Vol. 12, No. 4 USP Changes – Medical Devices Chapter / LAL Label Claim Sensitivity
- Vol. 12, No. 2 Potency, Certificates of Analysis and International Standards
- Vol. 11, No. 5 Depyrogenation
- Vol. 11, No. 4 Endotoxin Standards and CSE Potency
- Vol. 9, No. 2 Glitches with Glass
- Vol. 6, No. 3 The Problems with Plastics
